For the year ending 2025-12-31, COCHW had -$1,744K decrease in cash & cash equivalents over the period. -$18,380K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -23,756 |
| Depreciation | 302 |
| Interest expense and amortization of debt discount on term loans (related party) | 1,590 |
| Stock-based compensation for services | 88 |
| Amortization of prepaid insurance | 964 |
| Stock-based compensation | 657 |
| Change in fair value of private warrant liability | 494 |
| Change in fair value of publicly traded warrant liability | -111 |
| Change in fair value of forward purchase agreement warrant liability | -534 |
| Change in fair value of forward purchase agreement warrant liability due to extension | 24 |
| Net change in operating lease right-of-use assets and liability (related party) | 206 |
| Change in inventory reserve | 36 |
| Accounts receivable, net | -4 |
| Other receivable | -761 |
| Inventories | -126 |
| Prepaid expenses and other current assets | 8 |
| Accounts payable | 1,385 |
| Operating lease liability (related party) | -239 |
| Accrued expenses | 839 |
| Product warranty liability | -161 |
| Other liability | -868 |
| Net cash used in operating activities | -18,201 |
| Purchases of property and equipment | 179 |
| Net cash used in investing activities | -179 |
| Payments on insurance financing loans | 827 |
| Proceeds from the issuance of term loans (related party) | 10,000 |
| Dividends paid to stockholders of series a preferred stock | 1,819 |
| Payment made for extinguishment of term loans (related party) | 100 |
| Proceeds from the issuance of class a common stock from atm offering | 414 |
| Proceeds from issuance of class a common stock under employee stock purchase plan | 184 |
| Proceeds from exercise of forward purchase agreement warrants | 3,111 |
| Proceeds from the issuance of class a common stock and investor warrants from registered direct offering | 6,500 |
| Offering costs from the issuance of class a common stock and investor warrants from registered direct offering | 768 |
| Deferred offering costs | 62 |
| Net cash provided by financing activities | 16,633 |
| Effect of exchange rate changes on cash | 3 |
| Net (decrease) increase in cash | -1,744 |
| Cash, beginning of year | 5,483 |
| Cash, end of year | 3,739 |
Envoy Medical, Inc. (COCHW)
Envoy Medical, Inc. (COCHW)